About AskBio
AskBio is a company based in Durham (United States) founded in 2001 by Jude Samulski and Sheila Mikhail was acquired by Bayer in October 2020.. AskBio has raised $235 million across 8 funding rounds from investors including Bayer, TPG and HHS. AskBio has completed 2 acquisitions, including Brain Vectis and Synpromics. AskBio offers products and services including AAV Gene Therapy Platform and Discovery Program. AskBio operates in a competitive market with competitors including Jazz Pharmaceuticals, Spark Therapeutics, Amyris, Biogen and Neurocrine, among others.
- Headquarter Durham, United States
- Founders Jude Samulski, Sheila Mikhail
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Synpromics Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$235 M (USD)
in 8 rounds
-
Latest Funding Round
$2.68 M (USD), Grant
Sep 02, 2020
-
Investors
Bayer
& 4 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Brain Vectis
& 1 more
-
Acquired by
Bayer
(Oct 26, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AskBio
AskBio offers a comprehensive portfolio of products and services, including AAV Gene Therapy Platform and Discovery Program. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for developing treatments targeting genetic diseases using AAV vectors.
Program enabling partnerships for advancing gene therapy innovations.
Unlock access to complete
Leadership Team
37 people
Software Development Team
21 people
Product Management Team
14 people
Scientist Team
12 people
Senior Team
8 people
Operations Team
7 people
Research Team
5 people
Human Resources and Administration
3 people
Unlock access to complete
Funding Insights of AskBio
AskBio has successfully raised a total of $235M across 8 strategic funding rounds. The most recent funding activity was a Grant round of $2.68 million completed in September 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Grant — $2.7M
-
First Round
First Round
(26 Sep 2008)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2020 | Amount | Grant - AskBio | Valuation |
investors |
|
| Apr, 2019 | Amount | Private Equity Round - AskBio | Valuation | Vida Ventures , TPG |
|
| Aug, 2014 | Amount | Grant - AskBio | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in AskBio
AskBio has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Bayer, TPG and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biomedical innovations are transformed into therapies by Vida Ventures.
|
Founded Year | Domain | Location | |
|
Fund of funds focused on pre-seed and seed-stage companies
|
Founded Year | Domain | Location | |
|
Business development and leadership training programs are offered to companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by AskBio
AskBio has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Brain Vectis and Synpromics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of gene therapies for the treatment of Alzheimer's and Huntington's disease
|
2015 | ||||
|
Synthetic promoters are designed for specific gene regulation.
|
2010 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - AskBio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Askbio Comparisons
Competitors of AskBio
AskBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Spark Therapeutics, Amyris, Biogen and Neurocrine, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
Developer of renewable products for industrial solutions
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Developer of small molecule therapeutics for endocrine and CNS disorders
|
|
| domain | founded_year | HQ Location |
Small molecule drugs for rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Askbio
Frequently Asked Questions about AskBio
When was AskBio founded?
AskBio was founded in 2001 and raised its 1st funding round 7 years after it was founded.
Where is AskBio located?
AskBio is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Who is the current CEO of AskBio?
Sheila Mikhail is the current CEO of AskBio. They have also founded this company.
Is AskBio a funded company?
AskBio is a funded company, having raised a total of $235M across 8 funding rounds to date. The company's 1st funding round was a Grant of $270.01K, raised on Sep 26, 2008.
What does AskBio do?
AskBio was founded in 2001 in Durham, United States, and operates in the biotechnology sector. Novel protein and cellular-based therapies are developed and delivered using a proprietary platform of recombinant adeno-associated virus biological nanoparticles. This technology enables high transduction efficiency, controlled expression, and targeted tissue delivery. The product pipeline encompasses treatments for muscular dystrophy, hemophilia B in Phase 1 trials, congestive heart failure, epilepsy, retinitis pigmentosa, and osteoporosis.
Who are the top competitors of AskBio?
AskBio's top competitors include Jazz Pharmaceuticals, Spark Therapeutics and Syngenta.
What products or services does AskBio offer?
AskBio offers AAV Gene Therapy Platform and Discovery Program.
How many acquisitions has AskBio made?
AskBio has made 2 acquisitions, including Brain Vectis, and Synpromics.
Who are AskBio's investors?
AskBio has 5 investors. Key investors include Bayer, TPG, HHS, Scottish Enterprise, and Vida Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.